This collaboration aims to advance the adoption of Radiobotics’ flagship product, RBfracture™, in the Israeli healthcare system and surrounding regions
November 01, 2024 — Copenhagen, Denmark — Radiobotics, a leading provider of AI-powered solutions for musculoskeletal (MSK) radiology, is proud to announce its strategic partnership with K2Ai, a prominent health-tech provider in Israel. This collaboration aims to advance the adoption of Radiobotics’ flagship product, RBfracture™, in the Israeli healthcare system and surrounding regions.
The partnership is a significant step toward Radiobotics’ vision that every patient should receive expert-level care in MSK imaging, regardless of time, infrastructure, or staffing constraints.
“This partnership aligns perfectly with our vision,”
says Peter Ulvskjold, CEO of Radiobotics.
“K2Ai’s expertise in integrating innovative healthcare solutions in a range of institutions — hospitals, clinics, startups, multinational corporations, and military — enhances patients’ accessibility to expert-level care in MSK imaging.”
K2Ai is equally enthusiastic to utilise its deep understanding of the local and regional healthcare ecosystems to improve efficiency and patient outcomes.
“RBfracture is an exceptional tool that we believe will resonate strongly with our network,”
says Kfir Kaper, CEO at K2Ai.
“We’re excited to partner with Radiobotics to bring the world’s most advanced diagnostic technologies to Israel, help elevate patient care to the next level, and transform the medical technology landscape. We’re thrilled to have such excellent partners as we expand our collaborations to the Middle East, and Eastern Europe.”
Kobi Gelbgisser, VP of BizDev at K2Ai, adds:
“Beyond saving time for physicians and patients and reducing downstream costs, RBfracture offers real early-detection opportunities and the potential to create meaningful change in healthcare routine.”
RBfracture automatically detects trauma-related findings, such as fractures, dislocations, and lipohemarthrosis, on MSK X-rays, offering significant clinical value in emergency and trauma care settings. By integrating RBfracture into their portfolio, K2Ai enhances its ability to provide innovative, effective, and accessible healthcare solutions that support clinical decision-making.
About K2Ai:
K2Ai specialises in integrating proven AI technologies into the Israeli healthcare landscape. We are committed to transforming medical practices by deploying cutting-edge solutions that enhance decision-making, reduce operational burdens, and alleviate workforce shortages. We drive transformation by introducing and implementing the most advanced health technologies, ensuring they lead to lasting changes in healthcare practices. This aligns with our long-term goals for improved system efficiency and better patient outcomes.
About Radiobotics:
Founded in 2017, Radiobotics is an award-winning MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusions.
Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, has been recognized in the industry with numerous accolades, including Best New Radiology Vendor at the EuroMinnies 2022, a nomination for Digital Europe’s Future Unicorn Award in 2021, and a 2020 EIC Accelerator grant.
בניית אתרים JUNAMI